Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pharmaceutical composition for treating vascular dementia and its application

A technology for vascular dementia and a composition, applied in the field of medicine, can solve problems such as difficulty in curing vascular dementia, and achieve obvious effects and improve cognition.

Inactive Publication Date: 2015-09-23
XINXIANG MEDICAL UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, it is still difficult to cure vascular dementia, but most of the symptoms can be improved through drug treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating vascular dementia and its application
  • Pharmaceutical composition for treating vascular dementia and its application
  • Pharmaceutical composition for treating vascular dementia and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] A pharmaceutical composition for treating vascular dementia, which comprises the following raw materials formulated in parts by weight: 10 parts of Lycium barbarum polysaccharide component-III, 10 parts of Lycium barbarum polysaccharide component-I, 310 parts of Astragalus polysaccharide component A, motherwort 7 parts of glycoside A, 7 parts of forsythin and 5 parts of terpene-3β-alcohol.

Embodiment 2

[0034]A pharmaceutical composition for treating vascular dementia, which comprises the following raw materials formulated in parts by weight: 55 parts of Lycium barbarum polysaccharide component-III, 55 parts of Lycium barbarum polysaccharide component-I, 355 parts of Astragalus polysaccharide component A, motherwort 53.5 parts of glycoside A, 53.5 parts of forsythin and 52.5 parts of terpene-3β-alcohol.

Embodiment 3

[0036] A pharmaceutical composition for treating vascular dementia, which comprises the following raw materials formulated in parts by weight: 80 parts of Lycium barbarum polysaccharide component-III, 80 parts of Lycium barbarum polysaccharide component-I, 380 parts of Astragalus polysaccharide component A, motherwort 80 parts of glycoside A, 80 parts of forsythin and 80 parts of terpene-3β-alcohol.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine, particularly relates to a medicinal composition for treating vascular dementia and application thereof. The medicinal composition is prepared from the following raw materials: lycium barbarum polysaccharide component III, lycium barbarum polysaccharide component I, astragalus polysaccharide component A3, ajugol A, phillyrin and friedelin-3beta-ol. The medicinal composition provided by the invention has distinct therapeutic effect on vascular dementia, has stable quality control, and is suitable for long-term administration of patients.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating vascular dementia and its application. Background technique [0002] Vascular dementia (VD) refers to the acquired intelligence impairment syndrome caused by brain dysfunction caused by various cerebrovascular diseases. A group of psychotic syndromes mainly characterized by impairment of memory and cognitive functions, accompanied by speech, movement, visuospatial and personality disorders as the main clinical manifestations. Vascular dementia is a frequently-occurring and common disease among middle-aged and elderly people, and it is one of the main types of senile dementia. Statistics show that in European and American countries, vascular dementia accounts for 15% of the total number of senile dementias; in China, Japan and other Asian countries, vascular dementia accounts for 50% of the total number of senile dementias. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/715A61P25/28A61P9/00A61K31/7048A61K31/56
Inventor 尹雅玲白瑞樱牛杰路军秀张红涛王永霞杨静孙瑞利马丽娟
Owner XINXIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com